Loading the comparison…
Loading the comparison…
Cognitive & Mood
A three-amino-acid Khavinson 'bioregulator' aimed at the brain.
Longevity & Skin
A Russian 'bioregulator' tripeptide aimed at cartilage — with very limited evidence.
Pinealon is not FDA-approved and rated 2/5 for evidence; Cartalax is not FDA-approved and rated 1/5. Pinealon has more human evidence behind it. Both are banned in sport by WADA. Pinealon is listed under Cognitive & Mood; Cartalax under Longevity & Skin.
| Compare | Pinealon A three-amino-acid Khavinson 'bioregulator' aimed at the brain. | Cartalax A Russian 'bioregulator' tripeptide aimed at cartilage — with very limited evidence. |
|---|---|---|
| Category | Cognitive & Mood | Longevity & Skin |
| Evidence | 2/5Cell and animal studies from the developing group; one small uncontrolled human cohort. No placebo-controlled trials. | 1/5Mostly in-vitro and animal work from one research group. No independent controlled human trials. |
| FDA status | Not FDA-approved | Not FDA-approved |
| WADA (sport) | Banned | Banned |
| Also known as | EDR, Glu-Asp-Arg | AED peptide, Ala-Glu-Asp, T-31 |
| How it works | Proposed to enter cells and interact with DNA to influence gene activity, and to reduce oxidative stress in neurons. These ideas come mainly from the developers' lab and are not independently confirmed. | Proposed to enter cells and interact with DNA and chromatin, adjusting gene activity in cartilage and connective-tissue cells. In cell studies it is reported to influence markers of cell aging and repair. This 'gene-regulating short peptide' model has not been independently confirmed. |
| Half-life | Not well characterized; likely short | Not characterized |
| Commonly reported doses |
|
|
| Route | Subcutaneous | Subcutaneous |
| Good once mixed | ~30 days in the fridge | ~28 days in the fridge |
| Top side effects |
|
|
| Lowest research-listing price per mg | $3.00 (10 mg vial, 40% off) | $2.10 (20 mg vial, 40% off) |
| Latest lab purity | 99.90% (lot PIN0002) | 99.90% (lot CTX0002) |
Want a third? Add another peptide. Doses are commonly reported ranges, not recommendations.
Free for ChatGPT and Claude
Connect MyPeps to ChatGPT or Claude and ask follow-ups about Pinealon and Cartalax. It answers from these same pages, with links back here.
Pinealon is not FDA-approved and rated 2/5 for evidence; Cartalax is not FDA-approved and rated 1/5. Pinealon has more human evidence behind it. Both are banned in sport by WADA. Pinealon is listed under Cognitive & Mood; Cartalax under Longevity & Skin.
Pinealon: Not FDA-approved. Cartalax: Not FDA-approved. Regulations change, so confirm with the FDA.
Pinealon is rated 2 out of 5: Cell and animal studies from the developing group; one small uncontrolled human cohort. No placebo-controlled trials. Cartalax is rated 1 out of 5: Mostly in-vitro and animal work from one research group. No independent controlled human trials. The scale is explained on our methodology page.
Pinealon is banned by WADA, by name or as part of a named class. Cartalax is banned by WADA, by name or as part of a named class.